S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year…  (Ad)pixel
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Trade With Artificial Intelligence for Happiness (Ad)pixel
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
Trade With Artificial Intelligence for Happiness (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year…  (Ad)pixel
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Trade With Artificial Intelligence for Happiness (Ad)pixel
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
Trade With Artificial Intelligence for Happiness (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year…  (Ad)pixel
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Trade With Artificial Intelligence for Happiness (Ad)pixel
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
Trade With Artificial Intelligence for Happiness (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
S&P 500   3,585.62
DOW   28,725.51
QQQ   267.26
Want to Increase Your Conversion Rates? This Is the Biggest Threat to Your Success.
In 20 years, this little-known trader didn’t have a single losing year…  (Ad)pixel
EV Battery Maker Freyr Set For Major Global Expansion
Russia accused of 'kidnapping' head of Ukraine nuclear plant
Trade With Artificial Intelligence for Happiness (Ad)pixel
How major US stock indexes fared Friday 9/30/2022
Putin accuses the West of sabotaging Baltic Sea pipelines
Trade With Artificial Intelligence for Happiness (Ad)pixel
West rejects Putin's claim it sabotaged Baltic gas pipelines
NATO chief rejects Russia’s “illegal and illegitimate” annexation of 4 parts of Ukraine
NASDAQ:SRTS

Sensus Healthcare - SRTS Stock Forecast, Price & News

$12.53
+0.56 (+4.68%)
(As of 09/30/2022 12:00 AM ET)
Add
Compare
Today's Range
$11.88
$12.69
50-Day Range
$9.73
$14.97
52-Week Range
$3.59
$15.25
Volume
381,948 shs
Average Volume
336,500 shs
Market Capitalization
$207.50 million
P/E Ratio
8.30
Dividend Yield
N/A
Price Target
$13.50

Sensus Healthcare MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
7.7% Upside
$13.50 Price Target
Short Interest
Healthy
3.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.23mentions of Sensus Healthcare in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$1.13 M Sold Last Quarter
Proj. Earnings Growth
23.38%
From $0.77 to $0.95 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.04 out of 5 stars

Medical Sector

673rd out of 1,093 stocks

Surgical & Medical Instruments Industry

69th out of 106 stocks

SRTS stock logo

About Sensus Healthcare (NASDAQ:SRTS) Stock

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a SRT-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and in-office laser rental services. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.

Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Stock News Headlines

SRTS Sensus Healthcare, Inc.
Take Advantage of the Dip: 3 Top Stocks To Consider
See More Headlines
Receive SRTS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sensus Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SRTS Company Calendar

Last Earnings
8/04/2022
Today
10/01/2022
Next Earnings (Estimated)
11/03/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:SRTS
Employees
37
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$13.50
High Stock Price Forecast
$14.00
Low Stock Price Forecast
$13.00
Forecasted Upside/Downside
+7.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$4.12 million
Pretax Margin
65.46%

Debt

Sales & Book Value

Annual Sales
$27.04 million
Cash Flow
$0.30 per share
Book Value
$1.57 per share

Miscellaneous

Free Float
13,847,000
Market Cap
$207.50 million
Optionable
Not Optionable
Beta
0.77

Key Executives

  • Mr. Joseph C. SardanoMr. Joseph C. Sardano (Age 69)
    Co-Founder, Chairman & CEO
    Comp: $630.45k
  • Mr. Michael J. Sardano (Age 33)
    Pres & Gen. Counsel
    Comp: $273.37k
  • Mr. Javier Rampolla (Age 49)
    Chief Financial Officer
  • Mr. Nicolas Soro (Age 37)
    Chief Operating Officer
  • Mr. Yonatan Vainer (Age 35)
    Chief Technology Officer
  • Mr. Benson Suen
    VP of International Sales
  • Dr. Mark S. Nestor
    Medical Director & Member of Medical Advisory Board
  • Dr. Clay Jefferies Cockerell (Age 65)
    Clinical Director & Member of Medical Advisory Board













SRTS Stock - Frequently Asked Questions

Should I buy or sell Sensus Healthcare stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Sensus Healthcare in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" SRTS shares.
View SRTS analyst ratings
or view top-rated stocks.

What is Sensus Healthcare's stock price forecast for 2022?

2 equities research analysts have issued 1-year target prices for Sensus Healthcare's stock. Their SRTS share price forecasts range from $13.00 to $14.00. On average, they predict the company's share price to reach $13.50 in the next twelve months. This suggests a possible upside of 7.7% from the stock's current price.
View analysts price targets for SRTS
or view top-rated stocks among Wall Street analysts.

How have SRTS shares performed in 2022?

Sensus Healthcare's stock was trading at $7.22 at the start of the year. Since then, SRTS stock has increased by 73.5% and is now trading at $12.53.
View the best growth stocks for 2022 here
.

When is Sensus Healthcare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 3rd 2022.
View our SRTS earnings forecast
.

How were Sensus Healthcare's earnings last quarter?

Sensus Healthcare, Inc. (NASDAQ:SRTS) released its earnings results on Thursday, August, 4th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.18 by $0.03. The company had revenue of $12.08 million for the quarter, compared to analysts' expectations of $10.28 million. Sensus Healthcare had a trailing twelve-month return on equity of 36.74% and a net margin of 61.26%.

What other stocks do shareholders of Sensus Healthcare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Sensus Healthcare investors own include Ring Energy (REI), Sorrento Therapeutics (SRNE), Corbus Pharmaceuticals (CRBP), Nabriva Therapeutics (NBRV), Sangamo Therapeutics (SGMO), Viking Therapeutics (VKTX), Vaxart (VXRT), Amarin (AMRN), Palatin Technologies (PTN) and QUALCOMM (QCOM).

When did Sensus Healthcare IPO?

(SRTS) raised $20 million in an IPO on Wednesday, March 30th 2016. The company issued 1,800,000 shares at $10.00-$12.00 per share. Joseph Gunnar and Feltl and Company served as the underwriters for the IPO and Neidiger, Tucker, Bruner was co-manager.

What is Sensus Healthcare's stock symbol?

Sensus Healthcare trades on the NASDAQ under the ticker symbol "SRTS."

How do I buy shares of Sensus Healthcare?

Shares of SRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sensus Healthcare's stock price today?

One share of SRTS stock can currently be purchased for approximately $12.53.

How much money does Sensus Healthcare make?

Sensus Healthcare (NASDAQ:SRTS) has a market capitalization of $207.45 million and generates $27.04 million in revenue each year. The company earns $4.12 million in net income (profit) each year or $1.51 on an earnings per share basis.

How can I contact Sensus Healthcare?

Sensus Healthcare's mailing address is 851 BROKEN SOUND PARKWAY NW SUITE 215, BOCA RATON FL, 33487. The official website for the company is www.sensushealthcare.com. The company can be reached via phone at (561) 922-5808, via email at kgolodetz@lhai.com, or via fax at 561-948-2071.

This page (NASDAQ:SRTS) was last updated on 10/1/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.